Publication | Closed Access

Pluronic® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin

Cell-based Drug DeliveryNanomedicineMucosal VaccinationChitosan MicrospheresBordetella BronchisepticaMedicineImmunologyPluronic® F127Nano-drug DeliveryDrug Delivery SystemPharmacology